tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND
US Market

Ligand Pharma (LGND) Ratios

Compare
834 Followers

Ligand Pharma Ratios

LGND's free cash flow for Q4 2025 was $1.44. For the 2025 fiscal year, LGND's free cash flow was decreased by $ and operating cash flow was $0.95. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
22.23 22.23 8.93 14.15 2.67
Quick Ratio
21.98 21.98 8.55 12.72 2.53
Cash Ratio
4.67 4.67 1.95 1.37 0.46
Solvency Ratio
0.29 0.29 0.28 1.03 0.06
Operating Cash Flow Ratio
1.31 1.32 2.61 2.95 1.40
Short-Term Operating Cash Flow Coverage
44.95 45.08 0.00 0.00 1.80
Net Current Asset Value
$ 288.85M$ 288.85M$ 220.22M$ 151.13M$ 98.42M
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.29 <0.01 <0.01 0.12
Debt-to-Equity Ratio
0.44 0.44 <0.01 <0.01 0.15
Debt-to-Capital Ratio
0.31 0.31 <0.01 <0.01 0.13
Long-Term Debt-to-Capital Ratio
0.30 0.30 0.00 0.00 0.00
Financial Leverage Ratio
1.53 1.53 1.13 1.12 1.28
Debt Service Coverage Ratio
51.84 144.50 11.28 138.71 0.51
Interest Coverage Ratio
23.37 0.00 -7.44 18.20 1.69
Debt to Market Cap
0.11 0.12 0.00 0.00 0.07
Interest Debt Per Share
22.99 23.35 0.55 0.39 5.31
Net Debt to EBITDA
1.41 1.43 -1.60 -0.17 0.53
Profitability Margins
Gross Profit Margin
97.54%97.54%93.37%73.31%73.08%
EBIT Margin
60.05%59.29%3.32%48.98%19.27%
EBITDA Margin
73.11%71.89%24.41%76.79%41.38%
Operating Profit Margin
17.61%17.61%-13.53%9.09%1.55%
Pretax Profit Margin
59.29%59.29%1.51%48.48%18.35%
Net Profit Margin
46.42%46.42%-2.41%39.72%-17.00%
Continuous Operations Profit Margin
46.42%46.42%-2.41%40.98%-2.66%
Net Income Per EBT
78.29%78.29%-160.13%81.93%-92.64%
EBT Per EBIT
336.79%336.79%-11.14%533.08%1185.74%
Return on Assets (ROA)
7.97%7.97%-0.43%6.63%-4.37%
Return on Equity (ROE)
13.86%12.23%-0.49%7.44%-5.58%
Return on Capital Employed (ROCE)
3.10%3.10%-2.50%1.55%0.46%
Return on Invested Capital (ROIC)
2.42%2.42%4.00%1.31%-0.06%
Return on Tangible Assets
12.00%12.00%-0.71%13.57%-10.96%
Earnings Yield
3.08%3.40%-0.21%4.22%-2.96%
Efficiency Ratios
Receivables Turnover
4.39 4.39 3.94 3.34 5.60
Payables Turnover
2.03 2.03 2.12 14.44 9.95
Inventory Turnover
0.72 0.72 0.78 1.46 3.97
Fixed Asset Turnover
24.84 24.84 6.74 5.24 7.14
Asset Turnover
0.17 0.17 0.18 0.17 0.26
Working Capital Turnover Ratio
0.35 0.49 0.65 0.68 0.67
Cash Conversion Cycle
409.36 409.36 385.42 333.61 120.35
Days of Sales Outstanding
83.12 83.12 92.70 109.27 65.17
Days of Inventory Outstanding
505.65 505.65 465.20 249.61 91.85
Days of Payables Outstanding
179.41 179.41 172.48 25.27 36.67
Operating Cycle
588.77 588.77 557.90 358.88 157.02
Cash Flow Ratios
Operating Cash Flow Per Share
2.49 2.55 5.31 2.87 8.17
Free Cash Flow Per Share
2.47 2.53 4.23 -0.25 7.11
CapEx Per Share
0.02 0.02 1.07 3.11 1.06
Free Cash Flow to Operating Cash Flow
0.99 0.99 0.80 -0.09 0.87
Dividend Paid and CapEx Coverage Ratio
108.88 109.20 4.94 0.92 7.69
Capital Expenditure Coverage Ratio
108.88 109.20 4.94 0.92 7.69
Operating Cash Flow Coverage Ratio
0.11 0.11 13.66 8.04 1.57
Operating Cash Flow to Sales Ratio
0.18 0.18 0.58 0.38 0.70
Free Cash Flow Yield
1.19%1.34%3.95%-0.35%10.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
32.46 29.38 -486.05 23.69 -33.78
Price-to-Sales (P/S) Ratio
15.23 13.64 11.73 9.41 5.74
Price-to-Book (P/B) Ratio
3.97 3.59 2.36 1.76 1.89
Price-to-Free Cash Flow (P/FCF) Ratio
83.75 74.76 25.32 -289.19 9.40
Price-to-Operating Cash Flow Ratio
82.09 74.07 20.19 24.92 8.17
Price-to-Earnings Growth (PEG) Ratio
0.20 >-0.01 4.53 -0.09 0.21
Price-to-Fair Value
3.97 3.59 2.36 1.76 1.89
Enterprise Value Multiple
22.25 20.41 46.44 12.09 14.40
Enterprise Value
4.36B 3.93B 1.89B 1.22B 1.17B
EV to EBITDA
22.25 20.41 46.44 12.09 14.40
EV to Sales
16.27 14.67 11.34 9.28 5.96
EV to Free Cash Flow
89.43 80.41 24.48 -285.26 9.75
EV to Operating Cash Flow
88.61 79.68 19.52 24.58 8.48
Tangible Book Value Per Share
25.01 25.51 25.07 17.22 8.25
Shareholders’ Equity Per Share
51.57 52.60 45.40 40.52 35.42
Tax and Other Ratios
Effective Tax Rate
0.22 0.22 2.60 0.15 1.14
Revenue Per Share
13.59 13.86 9.14 7.59 11.63
Net Income Per Share
6.31 6.44 -0.22 3.02 -1.98
Tax Burden
0.78 0.78 -1.60 0.82 -0.93
Interest Burden
0.99 1.00 0.45 0.99 0.95
Research & Development to Revenue
0.30 0.30 0.13 0.19 0.18
SG&A to Revenue
0.34 0.34 0.47 0.40 0.36
Stock-Based Compensation to Revenue
0.11 0.00 0.25 0.20 0.31
Income Quality
0.40 0.40 -24.07 0.95 -4.13
Currency in USD